NASDAQ · Medical - Instruments & Supplies

PLSE (PLSE) Stock

$35.13 +0.26% NASDAQ: PLSE Healthcare

Valuation

MetricValue
Price$35.13
Market Cap$2.43B
P/E Ratio-23.78
P/B Ratio26.67
P/S Ratio2389.16
EPS (TTM)$-0.88
52-Week High$35.13
52-Week Low$12.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-80.72%
ROA-45.03%
ROCE-95.06%
Gross Margin-91.08%
Operating Margin-103.92%
Net Margin-99.29%
Debt/Equity0.11
Current Ratio10.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$0$0$0
Operating Profit$-63.0M$-58.0M$-44.0M$-56.0M$-77.0M
Net Profit$-64.0M$-59.0M$-42.0M$-54.0M$-73.0M
EPS$-2.28$-1.72$-0.88$-0.92$-1.08
Op Margin-4443.9%-8293.9%——-21982.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$78.0M$59.0M$132.0M$96.0M
Total Liabilities$19.0M$80.0M$15.0M$18.0M$15.0M
Cash$29.0M$61.0M$44.0M$118.0M$81.0M
Borrowings$11.0M$76.0M$9.0M$9.0M$8.0M

Latest News

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 Business Wire · Jul 21, 2026 Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jul 15, 2026 Sector Update: Healthcare Stocks Mixed Premarket Wednesday MT Newswires · Jun 10, 2026 Pulse Biosciences to Redeem Remaining Warrants From July 2024 Offering MT Newswires · Jun 10, 2026 Pulse Biosciences, Inc. Announces Planned Redemption of Warrants Business Wire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-47.0M$-33.0M$-36.0M$-54.0M
Investing Cash Flow$7.0M$-1.0M$0$0$-1.0M
Financing Cash Flow$63.0M$0$0$50.0M$0
Net Cash Flow$16.0M$33.0M$-17.0M$74.0M$-37.0M
Free Cash Flow$-55.0M$-47.0M$-33.0M$-36.0M$-54.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-22.68
FCF Yield-3.09%
Quick Ratio7.24
Interest Coverage—
Return 1Y116.09%
Return 3Y392.63%
Return 5Y63.31%

Ownership

Insiders Held73.21%
Institutions Held12.30%
Institutions Float Held45.90%
Institutional HolderSharesReport Date
Blackrock Inc.1,339,7782026-03-31
Bank of America Corporation866,0612026-03-31
Vanguard Capital Management LLC815,8522026-03-31
Portolan Capital Management, LLC733,3722026-03-31
Geode Capital Management, LLC491,9462026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATAI $7.25 +0.97% -8.44 $2.68B 0.00%
BBNX $15.90 +12.69% -6.53 $715.34M 0.00%
DNTH $104.09 +2.44% -17.99 $4.35B 0.00%
IMTX $8.24 -4.52% -4.98 $1.10B 0.00%
KMTS $23.99 +5.08% -3.85 $1.41B 0.00%

About PLSE

PLSE stock trades at $35.13 with a market capitalization of $2.43B. The stock is valued at a price-to-earnings (P/E) ratio of -23.78, price-to-book of 26.67, price-to-sales of 2389.16. Over the past 52 weeks the stock has ranged between $12.56 and $35.13, and currently trades at its 52-week high.

On profitability, PLSE generates a return on equity (ROE) of -80.72%, return on capital employed of -95.06%, an operating margin of -103.92%, a net profit margin of -99.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides